• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Difficult to Advance (2920)
Patient Problems Hemorrhage/Bleeding (1888); Perforation of Vessels (2135)
Event Date 12/11/2023
Event Type  Injury  
Event Description
It was reported that a versacross access solution was selected for use.During the procedure, the physician got access on the patient.While putting up the versacross rf wire and the connect system, it was not possible to advance the wire.It was noted on contrast imaging that the femoral vein appeared to have little leaks.The physician suspected that the was sheath scratched the femoral vein during insertion and/or advancement.The physician left the was sheath in placed and accessed the opposite side of the patient to place a stent on the femoral vein leaks.The was was removed, and a non-bsc introducer sheath was advanced along with a new was.The patient remained stable, and the procedure was completed successfully.The device is not expected to be returned for analysis.The patient was admitted to hospital beyond standard of care.It was further reported that in the physician's opinion, the versacross dilator and the versacross rf wire did not contribute to the scratch in the femoral vein.It was confirmed the product used (versacross connect).No noticeable damage to the catheter or sheath that could have caused or contributed.It was tried to use straight mechanical guidewire and also had difficulty.A difficult vein anatomy was noted during the case.The patient was discharged.Case was completed successfully.No other issues were reported.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18510258
MDR Text Key332871534
Report Number2124215-2023-74005
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age84 YR
Patient SexMale
-
-